20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction

I. Jung Tsai, Kevin D. Croft, Trevor A. Mori, J R Falck, Lawrence J. Beilin, Ian B. Puddey, Anne E. Barden

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

20-Hydroxyeicosatetraenoic acid (20-HETE) is a cytochrome P450 metabolite of arachidonic acid that regulates vascular function and sodium homeostasis. Studies showing an association between 20-HETE excretion, raised BMI, and oxidative stress suggest that 20-HETE may be important in the development of cardiovascular disease in the metabolic syndrome (MetS). We investigated whether 20-HETE and F2-isoprostanes (markers of oxidative stress) were altered in the MetS before and after weight reduction. A case-controlled comparison of 30 participants with the MetS and matched controls showed that plasma and urinary 20-HETE and F2-isoprostanes were significantly elevated in the MetS group. There was a significant gender × group interaction such that women with the MetS had higher urinary 20-HETE and F2-isoprostanes compared to controls (p < 0.0001). In a randomized controlled trial, 42 participants with the MetS were assigned to 16 weeks of weight maintenance or a 12-week weight-loss program followed by 4 weeks weight stabilization. Relative to the weight-maintenance group, a 4-kg loss in weight resulted in a 2-mm Hg fall in blood pressure (BP) but did not alter urinary or plasma 20-HETE or F2-isoprostanes. 20-HETE and oxidative stress may be important mediators of cardiovascular disease risk in the MetS. Although a 4% reduction in body weight reduced BP, there were no changes in plasma or urinary 20-HETE or F2-isoprostanes.

Original languageEnglish (US)
Pages (from-to)263-270
Number of pages8
JournalFree Radical Biology and Medicine
Volume46
Issue number2
DOIs
StatePublished - Jan 15 2009

Fingerprint

F2-Isoprostanes
Weight Loss
Oxidative stress
Oxidative Stress
Blood pressure
Plasmas
Weights and Measures
Cardiovascular Diseases
Maintenance
Blood Pressure
Weight Reduction Programs
20-hydroxy-5,8,11,14-eicosatetraenoic acid
Metabolites
Arachidonic Acid
Cytochrome P-450 Enzyme System
Blood Vessels
Homeostasis
Randomized Controlled Trials
Stabilization
Sodium

Keywords

  • F-isoprostanes
  • Free radicals
  • Metabolic syndrome
  • Plasma and urinary 20-HETE
  • Weight reduction

ASJC Scopus subject areas

  • Biochemistry
  • Physiology (medical)
  • Medicine(all)

Cite this

20-HETE and F2-isoprostanes in the metabolic syndrome : the effect of weight reduction. / Tsai, I. Jung; Croft, Kevin D.; Mori, Trevor A.; Falck, J R; Beilin, Lawrence J.; Puddey, Ian B.; Barden, Anne E.

In: Free Radical Biology and Medicine, Vol. 46, No. 2, 15.01.2009, p. 263-270.

Research output: Contribution to journalArticle

Tsai, I. Jung ; Croft, Kevin D. ; Mori, Trevor A. ; Falck, J R ; Beilin, Lawrence J. ; Puddey, Ian B. ; Barden, Anne E. / 20-HETE and F2-isoprostanes in the metabolic syndrome : the effect of weight reduction. In: Free Radical Biology and Medicine. 2009 ; Vol. 46, No. 2. pp. 263-270.
@article{d9a9891e9ab04c95b05c15a79b745ff1,
title = "20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction",
abstract = "20-Hydroxyeicosatetraenoic acid (20-HETE) is a cytochrome P450 metabolite of arachidonic acid that regulates vascular function and sodium homeostasis. Studies showing an association between 20-HETE excretion, raised BMI, and oxidative stress suggest that 20-HETE may be important in the development of cardiovascular disease in the metabolic syndrome (MetS). We investigated whether 20-HETE and F2-isoprostanes (markers of oxidative stress) were altered in the MetS before and after weight reduction. A case-controlled comparison of 30 participants with the MetS and matched controls showed that plasma and urinary 20-HETE and F2-isoprostanes were significantly elevated in the MetS group. There was a significant gender × group interaction such that women with the MetS had higher urinary 20-HETE and F2-isoprostanes compared to controls (p < 0.0001). In a randomized controlled trial, 42 participants with the MetS were assigned to 16 weeks of weight maintenance or a 12-week weight-loss program followed by 4 weeks weight stabilization. Relative to the weight-maintenance group, a 4-kg loss in weight resulted in a 2-mm Hg fall in blood pressure (BP) but did not alter urinary or plasma 20-HETE or F2-isoprostanes. 20-HETE and oxidative stress may be important mediators of cardiovascular disease risk in the MetS. Although a 4{\%} reduction in body weight reduced BP, there were no changes in plasma or urinary 20-HETE or F2-isoprostanes.",
keywords = "F-isoprostanes, Free radicals, Metabolic syndrome, Plasma and urinary 20-HETE, Weight reduction",
author = "Tsai, {I. Jung} and Croft, {Kevin D.} and Mori, {Trevor A.} and Falck, {J R} and Beilin, {Lawrence J.} and Puddey, {Ian B.} and Barden, {Anne E.}",
year = "2009",
month = "1",
day = "15",
doi = "10.1016/j.freeradbiomed.2008.10.028",
language = "English (US)",
volume = "46",
pages = "263--270",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - 20-HETE and F2-isoprostanes in the metabolic syndrome

T2 - the effect of weight reduction

AU - Tsai, I. Jung

AU - Croft, Kevin D.

AU - Mori, Trevor A.

AU - Falck, J R

AU - Beilin, Lawrence J.

AU - Puddey, Ian B.

AU - Barden, Anne E.

PY - 2009/1/15

Y1 - 2009/1/15

N2 - 20-Hydroxyeicosatetraenoic acid (20-HETE) is a cytochrome P450 metabolite of arachidonic acid that regulates vascular function and sodium homeostasis. Studies showing an association between 20-HETE excretion, raised BMI, and oxidative stress suggest that 20-HETE may be important in the development of cardiovascular disease in the metabolic syndrome (MetS). We investigated whether 20-HETE and F2-isoprostanes (markers of oxidative stress) were altered in the MetS before and after weight reduction. A case-controlled comparison of 30 participants with the MetS and matched controls showed that plasma and urinary 20-HETE and F2-isoprostanes were significantly elevated in the MetS group. There was a significant gender × group interaction such that women with the MetS had higher urinary 20-HETE and F2-isoprostanes compared to controls (p < 0.0001). In a randomized controlled trial, 42 participants with the MetS were assigned to 16 weeks of weight maintenance or a 12-week weight-loss program followed by 4 weeks weight stabilization. Relative to the weight-maintenance group, a 4-kg loss in weight resulted in a 2-mm Hg fall in blood pressure (BP) but did not alter urinary or plasma 20-HETE or F2-isoprostanes. 20-HETE and oxidative stress may be important mediators of cardiovascular disease risk in the MetS. Although a 4% reduction in body weight reduced BP, there were no changes in plasma or urinary 20-HETE or F2-isoprostanes.

AB - 20-Hydroxyeicosatetraenoic acid (20-HETE) is a cytochrome P450 metabolite of arachidonic acid that regulates vascular function and sodium homeostasis. Studies showing an association between 20-HETE excretion, raised BMI, and oxidative stress suggest that 20-HETE may be important in the development of cardiovascular disease in the metabolic syndrome (MetS). We investigated whether 20-HETE and F2-isoprostanes (markers of oxidative stress) were altered in the MetS before and after weight reduction. A case-controlled comparison of 30 participants with the MetS and matched controls showed that plasma and urinary 20-HETE and F2-isoprostanes were significantly elevated in the MetS group. There was a significant gender × group interaction such that women with the MetS had higher urinary 20-HETE and F2-isoprostanes compared to controls (p < 0.0001). In a randomized controlled trial, 42 participants with the MetS were assigned to 16 weeks of weight maintenance or a 12-week weight-loss program followed by 4 weeks weight stabilization. Relative to the weight-maintenance group, a 4-kg loss in weight resulted in a 2-mm Hg fall in blood pressure (BP) but did not alter urinary or plasma 20-HETE or F2-isoprostanes. 20-HETE and oxidative stress may be important mediators of cardiovascular disease risk in the MetS. Although a 4% reduction in body weight reduced BP, there were no changes in plasma or urinary 20-HETE or F2-isoprostanes.

KW - F-isoprostanes

KW - Free radicals

KW - Metabolic syndrome

KW - Plasma and urinary 20-HETE

KW - Weight reduction

UR - http://www.scopus.com/inward/record.url?scp=58049120210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58049120210&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2008.10.028

DO - 10.1016/j.freeradbiomed.2008.10.028

M3 - Article

C2 - 19013235

AN - SCOPUS:58049120210

VL - 46

SP - 263

EP - 270

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

IS - 2

ER -